Mikaela Knapp's friends, family and former colleagues at SparkPR are putting pressure on Merck to grant the compassionate use of a promising new immunotherapy drug.
Mikaela Knapp's friends, family and former colleagues at SparkPR are putting pressure on Merck to grant the compassionate use of a promising new immunotherapy drug.
Please to comment